Suppr超能文献

癫痫患者中拉莫三嗪的血清浓度:剂量和合并用药的影响。

Serum concentrations of lamotrigine in epileptic patients: the influence of dose and comedication.

作者信息

May T W, Rambeck B, Jürgens U

机构信息

Department of Biochemistry, Gesellschaft für Epilepsieforschung, Bielefeld, Germany.

出版信息

Ther Drug Monit. 1996 Oct;18(5):523-31. doi: 10.1097/00007691-199610000-00001.

Abstract

Lamotrigine (LTG) is a new antiepileptic drug (AED), chemically unrelated to the drugs in current use. Previous studies have shown that LTG has only a limited effect on other AEDs, but its own metabolism can be strongly induced or inhibited by the comedication. We investigated the influences of carbamazepine (CBZ), phenytoin (PHT), phenobarbital (PB), valproic acid (VPA), and combinations of these drugs on the serum concentration of LTG. A total of 588 blood samples from 302 patients were analyzed. The mean duration of LTG therapy was 141 +/- 137 days (mean +/- SD). A patient was only considered twice in this study if his or her comedication had been changed. The LTG serum concentration in relation to LTG dose/body weight (level-to-dose ratio, LDR, microgram/ml/mg/kg) was calculated and compared for different drug combinations. The results showed that comedication had a highly significant (p < 0.001) influence on the LTG serum concentrations. The mean LDR for LTG was 0.32 (LTG + PHT) < 0.52 (LTG + PB) approximately equal to 0.57 (LTG + CBZ) < 0.98 (LTG mono) approximately equal to 0.99 (LTG + VPA + PHT) < 1.67 (LTG + VPA + CBZ) approximately equal to 1.80 (LTG + VPA + PB) < 3.57 (LTG + VPA (<, p < 0.05; approximately equal to, p > 0.05, multiple comparisons). The mean LTG concentrations in patients on comedication with VPA were about two times higher than on patients on LTG monotherapy or on comedication without VPA (5.0 vs. 2.6 micrograms/ml), despite the LTG doses being half as high (3.0 vs. 5.9 mg/kg). The correlations of the serum concentrations and doses of CBZ, PB, PHT, and VPA with the LDR of LTG were only weak or not significant. Furthermore, the distribution of LTG serum concentrations and dosages was compared with the tentative therapeutic range for the LTG concentration (1-4 micrograms/ml), proposed by some investigators, and the recommendations for the LTG dosage. Remarkable discrepancies were observed. The comedication has an important influence on the LTG concentration and should be considered in LTG dosage.

摘要

拉莫三嗪(LTG)是一种新型抗癫痫药物(AED),其化学结构与目前使用的药物无关。先前的研究表明,LTG对其他抗癫痫药物的作用有限,但其自身代谢可被合并用药强烈诱导或抑制。我们研究了卡马西平(CBZ)、苯妥英(PHT)、苯巴比妥(PB)、丙戊酸(VPA)以及这些药物的组合对LTG血清浓度的影响。对302例患者的588份血样进行了分析。LTG治疗的平均持续时间为141±137天(平均值±标准差)。仅当患者的合并用药发生变化时,才在本研究中再次考虑该患者。计算并比较了不同药物组合下LTG血清浓度与LTG剂量/体重的关系(浓度-剂量比,LDR,微克/毫升/毫克/千克)。结果表明,合并用药对LTG血清浓度有极显著影响(p<0.001)。LTG的平均LDR为0.32(LTG+PHT)<0.52(LTG+PB)≈0.57(LTG+CBZ)<0.98(LTG单药治疗)≈0.99(LTG+VPA+PHT)<1.67(LTG+VPA+CBZ)≈1.80(LTG+VPA+PB)<3.57(LTG+VPA)(<,p<0.05;≈,p>0.05,多重比较)。尽管LTG剂量仅为一半(3.0对5.9毫克/千克),但接受VPA合并用药的患者中LTG的平均浓度比接受LTG单药治疗或无VPA合并用药的患者高约两倍(5.0对2.6微克/毫升)。CBZ、PB、PHT和VPA的血清浓度和剂量与LTG的LDR之间的相关性仅为弱相关或无显著相关性。此外,将LTG血清浓度和剂量的分布与一些研究者提出的LTG浓度暂定治疗范围(1-4微克/毫升)以及LTG剂量建议进行了比较。观察到明显差异。合并用药对LTG浓度有重要影响,在LTG给药时应予以考虑。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验